LicianPro

Dare Bioscience, Inc. ·

DARE 8-K 2026-10-01

Dare Bioscience, Inc. (DARE) 8-K dated 2026-10-01 — accession 0001493152-26-045275.

Dare Bioscience, Inc. (DARE) is a biotechnology company listed on US.

Dare Bioscience, Inc. filed a 8-K on 2026-10-01. Accession 0001493152-26-045275.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported DARE revenue for 2025-12-31 was $1.0M. Net income was -$13.4M. Revenue was down 63.3% from 2023-12-31 to 2025-12-31. DARE currently screens at market cap $21.2M.

Not investment advice. The DARE SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr